Biotechnology company Momenta Pharmaceuticals Inc. said the U.S. Food and Drug Administration approved its generic version of Sanofi-Aventis SA's Lovenox, an injected drug for preventing life-threatening blood clots.
Drugmakers Eisai Inc. and Pfizer Inc. said that government regulators have given them permission to make a larger dose of its Alzheimer's disease drug Aricept for patients who have already been taking the smaller dose.
Federal health advisers said a government proposal to curb misuse of powerful painkillers does not go far enough to fix a problem linked to hundreds of fatal overdoses annually.
Shares of Genzyme Corp. soared after a report was published that French pharmaceutical company Sanofi-Aventis is interested in the biotechnology drugmaker.
Labtronics Inc., a leader in laboratory automation has released a web based viewer for LimsLink, it's industry leading laboratory integration solution.
Affymetrix, Inc. announced that it has launched Axiom Custom Genotyping Arrays, the newest addition to the Axiom Genotyping Solution. Researchers can now leverage Affymetrix’ Axiom Genomic Database to create custom arrays.
Emir Duzic, PhD has joined ChanTest Corporation as head of GPCR and HTS Assay Services. Dr. Duzic has overall responsibility for developing, optimizing, standardizing and running all GPCR assays for customer compounds and all GPCR research projects.
Drug and medical device maker Baxter International Inc. said its net income fell 9 percent in the second quarter because of higher costs and a settlement with the government of Greece.
Scientists at the Virginia Bioinformatics Institute have constructed a mathematical and computational model of inflammatory bowel disease that allows researchers to simulate the cellular and molecular changes underlying chronic inflammation in humans.
A University of Minnesota Medical School research team has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease (SCD).
Results from the Phase 3 CAPRA-1 study of LODOTRA, showed sustained improvement in reducing the duration of morning stiffness in patients with rheumatoid arthritis.
Genticel, a biopharmaceutical company developing innovative therapeutic vaccines, announces that it has obtained approval to start a Phase 1 clinical trial with its candidate therapeutic HPV vaccine on adult women already infected with human papillomavirus (HPV).
Rich countries must give more for the fight against AIDS or risk jeopardizing progress in battling the disease, participants at an international conference urged.
A government investigator told members of Congress that personalized DNA tests claiming to predict certain inheritable diseases are misleading and offer little or no useful information.